Truemeds
PrivateLast Round
Series C
Aug 11, 2025
Est. Valuation
$400M
Total Funding Raised
$92M
Momentum Score
50 /100
Company Overview
Truemeds is an Indian e-pharmacy and telehealth platform founded in 2019 by Akshat Nayyar and Kunal Wani. The company operates as an online retailer of medicines and healthcare products, with a focus on providing affordable alternatives to branded medications. Through its proprietary algorithm and tele-consultations with doctors, Truemeds recommends clinically equivalent, cost-effective substitute medicines, claiming to help patients save significantly on their medical bills. The platform is venture-backed, having raised multiple funding rounds, including a Series C of $85 million in 2025. Headquartered in Mumbai, Truemeds delivers products across India and plans to expand its fulfillment centers and launch diagnostic services.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Mobile Commerce, Telemedicine, Pharma Supply Chain
Business Model
B2C
Customer Profile
Marketplace Commission, Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truemeds Comps
Public and private peers based on sector, stage, and business model.
Truemeds Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 11, 2025 | ||||
| Series B | Apr 26, 2022 | ||||
| Series A | Jun 8, 2021 |
Key People
Founding team and executive leadership
Truemeds Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peak XV Partners | Series C |
| Info Edge Ventures | Series C |
| Indian Angel Network Fund | Series A |
| WestBridge Capital | Series C, Series B |
| Info Edge Venture Fund | Series B, Series C |
| Asha Ventures | Series B |
| Accel | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Actor Paresh Rawal featured in upcoming campaign.
- Jan 1, 2026
Achieved 3.6x growth in revenue over two years.
Truemeds Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Truemeds's valuation, stock price, and market status.
